This investigation involves focus groups designed to collect patient opinions about a specific psychotherapy, called START NOW, as well as general beliefs about various elements of psychotherapy for treating opioid use disorder (OUD).
Clinical trials provide consistent evidence for buprenorphine’s efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear evidence for what form or elements of psychotherapy are most effective when coupled with MAT to treat OUD. The authors’ analysis reveals trends about patient preferences and strategies for improving OUD treatment. (Published abstract provided)
Downloads
Similar Publications
- The Treatment Group and Recidivism: A Multilevel Analysis of Prison-Based Substance Abuse Treatment
- New Synthetic Opioid Protonitazene Increasing in Prevalence as “Nitazenes” Gain Traction Across the United States and Canada
- Randomized Clinical Trial Pilot Study of Prolonged Exposure Versus Present Fcentred affect regulation therapy for PTSD and anger problems with male military combat veterans